Literature DB >> 19692466

Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.

Andrew C Brown1, Lorraine P Smith, Lydia Kgosana, Susan J Baigent, Venugopal Nair, Martin J Allday.   

Abstract

Marek's disease virus (MDV) is a lymphotropic alphaherpesvirus that induces fatal rapid-onset T-cell lymphomas in chickens, its natural host. The MDV-encoded nuclear oncoprotein Meq is essential for lymphomagenesis and acts as a regulator of transcription. Meq has structural features, including a basic domain adjacent to a leucine zipper motif (B-ZIP), that suggest it is related to the Jun/Fos family of transcription factors. Via the leucine zipper, Meq can form homodimers or heterodimerize with c-Jun. Meq/Meq homodimers are associated with transrepression, and Meq/Jun heterodimers can transactivate target genes carrying an AP-1-like binding site. In order to determine the role of the leucine zipper and of Meq dimerization in T lymphomagenesis, specific point mutations were engineered into the highly oncogenic RB-1B strain of MDV to produce virus completely lacking a functional Meq leucine zipper (RB-1B Meq(BZIP/BZIP)) or virus encoding Meq that cannot homodimerize but can still bind to c-Jun and an AP-1-like site on DNA (RB-1B Meq(Hom/Hom)). Both of these mutant viruses were capable of replication in cultured chicken embryo fibroblasts. However both mutations resulted in a complete loss of oncogenicity, since no lymphomas were produced up to 90 days postinfection in experimentally infected chicks. We conclude that the leucine zipper is necessary for the oncogenic activity of Meq and/or the efficient establishment of long-term MDV latency in T cells. Moreover, it appears that the ability to form homodimers is an absolute requirement and the ability to bind c-Jun alone is insufficient for the T-cell lymphomagenesis associated with virulent MDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692466      PMCID: PMC2772798          DOI: 10.1128/JVI.01393-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP).

Authors:  Mark Hickabottom; Gillian A Parker; Paul Freemont; Tim Crook; Martin J Allday
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

3.  Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

Authors:  Blanca Lupiani; Lucy F Lee; Xiaoping Cui; Isabel Gimeno; Amy Anderson; Robin W Morgan; Robert F Silva; Richard L Witter; Hsing-Jien Kung; Sanjay M Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

4.  Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome.

Authors:  G Pósfai; V Kolisnychenko; Z Bereczki; F R Blattner
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

Review 5.  Historical background.

Authors:  M A Epstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

6.  Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines.

Authors:  W E Briles; H A Stone; R K Cole
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

Review 7.  Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication.

Authors:  M S Parcells; V Arumugaswami; J T Prigge; K Pandya; R L Dienglewicz
Journal:  Poult Sci       Date:  2003-06       Impact factor: 3.352

8.  Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens.

Authors:  Paulette F Suchodolski; Yoshihiro Izumiya; Blanca Lupiani; Dharani K Ajithdoss; Oren Gilad; Lucy F Lee; Hsing-Jien Kung; Sanjay M Reddy
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

9.  Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.

Authors:  Alon M Levy; Yoshihiro Izumiya; Peter Brunovskis; Liang Xia; Mark S Parcells; Sanjay M Reddy; Lucy Lee; Hong-Wu Chen; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 10.  Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.

Authors:  J L Liu; H J Kung
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

View more
  23 in total

1.  Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.

Authors:  Annachiara Greco; Nadine Fester; Annemarie T Engel; Benedikt B Kaufer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

2.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivo.

Authors:  Keith W Jarosinski; Sina Arndt; Benedikt B Kaufer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

4.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

5.  Role of Marek's Disease Virus (MDV)-Encoded US3 Serine/Threonine Protein Kinase in Regulating MDV Meq and Cellular CREB Phosphorylation.

Authors:  Yifei Liao; Blanca Lupiani; Kanika Bajwa; Owais A Khan; Yoshihiro Izumiya; Sanjay M Reddy
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

6.  Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays.

Authors:  Aaron W Reinke; Gevorg Grigoryan; Amy E Keating
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

7.  Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.

Authors:  Annemarie T Engel; Ramesh K Selvaraj; Jeremy P Kamil; Nikolaus Osterrieder; Benedikt B Kaufer
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

8.  Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma.

Authors:  Andrew C Brown; Venugopal Nair; Martin J Allday
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

9.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

10.  Genetic evolution of Marek's disease virus in vaccinated poultry farms.

Authors:  Nahed Yehia; Hemat S El-Sayed; Sabry E Omar; Ahmed Erfan; Fatma Amer
Journal:  Vet World       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.